Report Detail
Global Pneumococcal Vaccine Market Growth 2019-2024
- RnM3051031 |
- 05 March, 2019 |
- Global |
- 131 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.
North America is the largest consumption market of Pneumococcal Vaccine with sales market share nearly 40% in 2015.
The second place is Europe, following North America with sales market share over 18% in 2016. Asia-Pacific is another important market of Pneumococcal Vaccine, enjoy nearly 16% sales market share in 2013, but the consumption experienced a sharp decrease due to approval of government departments in last few years.
According to this study, over the next five years the Pneumococcal Vaccine market will register a 1.0% CAGR in terms of revenue, the global market size will reach US$ 7580 million by 2024, from US$ 7140 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Pneumococcal Vaccine business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Pneumococcal Vaccine market by product type, application, key manufacturers and key regions and countries.
This study considers the Pneumococcal Vaccine value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
PPSV 23
PCV 7/13
PCV 10
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Child
Adult
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Pfizer
GSK
MSD
Sanofipasteur
CDIBP
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Pneumococcal Vaccine consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Pneumococcal Vaccine market by identifying its various subsegments.
Focuses on the key global Pneumococcal Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Pneumococcal Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Pneumococcal Vaccine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Pneumococcal Vaccine Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Pneumococcal Vaccine Consumption 2014-2024
- 2.1.2 Pneumococcal Vaccine Consumption CAGR by Region
- 2.2 Pneumococcal Vaccine Segment by Type
- 2.2.1 PPSV 23
- 2.2.2 PCV 7/13
- 2.2.3 PCV 10
- 2.3 Pneumococcal Vaccine Consumption by Type
- 2.3.1 Global Pneumococcal Vaccine Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Pneumococcal Vaccine Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Pneumococcal Vaccine Sale Price by Type (2014-2019)
- 2.4 Pneumococcal Vaccine Segment by Application
- 2.4.1 Child
- 2.4.2 Adult
- 2.5 Pneumococcal Vaccine Consumption by Application
- 2.5.1 Global Pneumococcal Vaccine Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Pneumococcal Vaccine Value and Market Share by Application (2014-2019)
- 2.5.3 Global Pneumococcal Vaccine Sale Price by Application (2014-2019)
3 Global Pneumococcal Vaccine by Players
- 3.1 Global Pneumococcal Vaccine Sales Market Share by Players
- 3.1.1 Global Pneumococcal Vaccine Sales by Players (2017-2019)
- 3.1.2 Global Pneumococcal Vaccine Sales Market Share by Players (2017-2019)
- 3.2 Global Pneumococcal Vaccine Revenue Market Share by Players
- 3.2.1 Global Pneumococcal Vaccine Revenue by Players (2017-2019)
- 3.2.2 Global Pneumococcal Vaccine Revenue Market Share by Players (2017-2019)
- 3.3 Global Pneumococcal Vaccine Sale Price by Players
- 3.4 Global Pneumococcal Vaccine Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Pneumococcal Vaccine Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Pneumococcal Vaccine Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Pneumococcal Vaccine by Regions
- 4.1 Pneumococcal Vaccine by Regions
- 4.1.1 Global Pneumococcal Vaccine Consumption by Regions
- 4.1.2 Global Pneumococcal Vaccine Value by Regions
- 4.2 Americas Pneumococcal Vaccine Consumption Growth
- 4.3 APAC Pneumococcal Vaccine Consumption Growth
- 4.4 Europe Pneumococcal Vaccine Consumption Growth
- 4.5 Middle East & Africa Pneumococcal Vaccine Consumption Growth
5 Americas
- 5.1 Americas Pneumococcal Vaccine Consumption by Countries
- 5.1.1 Americas Pneumococcal Vaccine Consumption by Countries (2014-2019)
- 5.1.2 Americas Pneumococcal Vaccine Value by Countries (2014-2019)
- 5.2 Americas Pneumococcal Vaccine Consumption by Type
- 5.3 Americas Pneumococcal Vaccine Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Pneumococcal Vaccine Consumption by Countries
- 6.1.1 APAC Pneumococcal Vaccine Consumption by Countries (2014-2019)
- 6.1.2 APAC Pneumococcal Vaccine Value by Countries (2014-2019)
- 6.2 APAC Pneumococcal Vaccine Consumption by Type
- 6.3 APAC Pneumococcal Vaccine Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Pneumococcal Vaccine by Countries
- 7.1.1 Europe Pneumococcal Vaccine Consumption by Countries (2014-2019)
- 7.1.2 Europe Pneumococcal Vaccine Value by Countries (2014-2019)
- 7.2 Europe Pneumococcal Vaccine Consumption by Type
- 7.3 Europe Pneumococcal Vaccine Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Pneumococcal Vaccine by Countries
- 8.1.1 Middle East & Africa Pneumococcal Vaccine Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Pneumococcal Vaccine Value by Countries (2014-2019)
- 8.2 Middle East & Africa Pneumococcal Vaccine Consumption by Type
- 8.3 Middle East & Africa Pneumococcal Vaccine Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Pneumococcal Vaccine Distributors
- 10.3 Pneumococcal Vaccine Customer
11 Global Pneumococcal Vaccine Market Forecast
- 11.1 Global Pneumococcal Vaccine Consumption Forecast (2019-2024)
- 11.2 Global Pneumococcal Vaccine Forecast by Regions
- 11.2.1 Global Pneumococcal Vaccine Forecast by Regions (2019-2024)
- 11.2.2 Global Pneumococcal Vaccine Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Pneumococcal Vaccine Forecast by Type
- 11.8 Global Pneumococcal Vaccine Forecast by Application
12 Key Players Analysis
- 12.1 Pfizer
- 12.1.1 Company Details
- 12.1.2 Pneumococcal Vaccine Product Offered
- 12.1.3 Pfizer Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Pfizer News
- 12.2 GSK
- 12.2.1 Company Details
- 12.2.2 Pneumococcal Vaccine Product Offered
- 12.2.3 GSK Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 GSK News
- 12.3 MSD
- 12.3.1 Company Details
- 12.3.2 Pneumococcal Vaccine Product Offered
- 12.3.3 MSD Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 MSD News
- 12.4 Sanofipasteur
- 12.4.1 Company Details
- 12.4.2 Pneumococcal Vaccine Product Offered
- 12.4.3 Sanofipasteur Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Sanofipasteur News
- 12.5 CDIBP
- 12.5.1 Company Details
- 12.5.2 Pneumococcal Vaccine Product Offered
- 12.5.3 CDIBP Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 CDIBP News
...
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Pneumococcal Vaccine . Industry analysis & Market Report on Pneumococcal Vaccine is a syndicated market report, published as Global Pneumococcal Vaccine Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Pneumococcal Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
